108 related articles for article (PubMed ID: 15571582)
21. Microscopic polyangiitis associated with primary biliary cirrhosis: a causal or casual association?
Amezcua-Guerra LM; Prieto P; Bojalil R; Pineda C; Amigo MC
J Rheumatol; 2006 Nov; 33(11):2351-3. PubMed ID: 16981285
[TBL] [Abstract][Full Text] [Related]
22. The role of an online community for people with a rare disease: content analysis of messages posted on a primary biliary cirrhosis mailinglist.
Lasker JN; Sogolow ED; Sharim RR
J Med Internet Res; 2005 Mar; 7(1):e10. PubMed ID: 15829472
[TBL] [Abstract][Full Text] [Related]
23. Decreased serum leptin levels in primary biliary cirrhosis: a link between metabolism and autoimmunity?
Rieger R; Oertelt S; Selmi C; Invernizzi P; Podda M; Gershwin ME
Ann N Y Acad Sci; 2005 Jun; 1051():211-7. PubMed ID: 16126961
[TBL] [Abstract][Full Text] [Related]
24. Transitions between variant forms of primary biliary cirrhosis during long-term follow-up.
Lindgren S; Glaumann H; Almer S; Bergquist A; Björnsson E; Broomé U; Danielsson A; Lebrun B; Prytz H; Olsson R
Eur J Intern Med; 2009 Jul; 20(4):398-402. PubMed ID: 19524182
[TBL] [Abstract][Full Text] [Related]
25. [Clinical and pathological characterization of the overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis].
Zhu GJ; Chen S; Mao Q; Wang YM
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):6-8. PubMed ID: 15670481
[TBL] [Abstract][Full Text] [Related]
26. Lack of association between appendectomy and primary biliary cirrhosis.
Rigopoulou EI; Georgiadou SP; Barbanis S; Dalekos GN
Scand J Gastroenterol; 2006 May; 41(5):573-6. PubMed ID: 16638700
[TBL] [Abstract][Full Text] [Related]
27. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.
Lan RY; Cheng C; Lian ZX; Tsuneyama K; Yang GX; Moritoki Y; Chuang YH; Nakamura T; Saito S; Shimoda S; Tanaka A; Bowlus CL; Takano Y; Ansari AA; Coppel RL; Gershwin ME
Hepatology; 2006 Apr; 43(4):729-37. PubMed ID: 16557534
[TBL] [Abstract][Full Text] [Related]
28. Overlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases.
Silveira MG; Lindor KD
Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):329-40. PubMed ID: 19072425
[TBL] [Abstract][Full Text] [Related]
29. Retroviruses and autoimmune endocrine diseases.
Coutant R; MacLaren NK
Ann Med Interne (Paris); 1999 Apr; 150(3):235-44. PubMed ID: 10445095
[No Abstract] [Full Text] [Related]
30. Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production.
Zachou K; Rigopoulou EI; Tsikrikoni A; Alexandrakis MG; Passam F; Kyriakou DS; Stathakis NE; Dalekos GN
J Autoimmun; 2005 Dec; 25(4):283-8. PubMed ID: 16242912
[TBL] [Abstract][Full Text] [Related]
31. Retrovirus infection as a trigger for primary biliary cirrhosis?
Poupon R; Poupon RE
Lancet; 2004 Jan; 363(9405):260-1. PubMed ID: 14751695
[No Abstract] [Full Text] [Related]
32. Late-onset sarcoidosis after liver transplantation for primary biliary cirrhosis.
Gur C; Lalazar G; Doviner V; Fridlender ZG; Molcho V; Abu-Much S; Shalit M; Elinav E
J Clin Gastroenterol; 2007 Mar; 41(3):329-32. PubMed ID: 17426476
[TBL] [Abstract][Full Text] [Related]
33. [Primary biliary cirrhosis and the overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis].
Wendum D
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S54-5. PubMed ID: 18984300
[No Abstract] [Full Text] [Related]
34. Other potential medical therapies: the use of antiviral agents to investigate and treat primary ciliary cirrhosis.
Mason AL; Wasilenko ST
Clin Liver Dis; 2008 May; 12(2):445-60; xi. PubMed ID: 18456190
[TBL] [Abstract][Full Text] [Related]
35. Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis.
Sánchez-Muñoz D; Castellano-Megías VM; Romero-Gómez M
Dig Liver Dis; 2007 Mar; 39(3):262-6. PubMed ID: 17270507
[TBL] [Abstract][Full Text] [Related]
36. Spectrum of autoimmune liver diseases in western India.
Amarapurkar DN; Patel ND
J Gastroenterol Hepatol; 2007 Dec; 22(12):2112-7. PubMed ID: 17623034
[TBL] [Abstract][Full Text] [Related]
37. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
Silveira MG; Lindor KD
Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
[TBL] [Abstract][Full Text] [Related]
38. [Liver cirrhosis in adults: etiology and specific treatments].
Fartoux L; Serfaty L
Rev Prat; 2005 Sep; 55(14):1539-48. PubMed ID: 16255295
[TBL] [Abstract][Full Text] [Related]
39. Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis.
Wang AP; Migita K; Ito M; Takii Y; Daikoku M; Yokoyama T; Komori A; Nakamura M; Yatsuhashi H; Ishibashi H
J Autoimmun; 2005 Aug; 25(1):85-91. PubMed ID: 16006099
[TBL] [Abstract][Full Text] [Related]
40. Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome.
Twaddell WS; Lefkowitch J; Berk PD
Semin Liver Dis; 2008 Feb; 28(1):128-34. PubMed ID: 18293283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
